Search
for

    Sort by

    Research 151–180 of 544

    1. Physiopathological role of the enzymatic complex 5α-reductase and 3α/β-hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites Frontiers in Neuroendocrinology · 2020 · 18 citations
    2. Exploring the neural mechanisms of finasteride: a proteomic analysis in the nucleus accumbens Psychoneuroendocrinology · 2016 · 14 citations
    3. Impact of Alpha Blockers, 5-alpha Reductase Inhibitors and Combination Therapy on Sexual Function Current Urology Reports · 2014 · 11 citations
    4. Progestogens in menopausal hormone therapy Przeglad Menopauzalny · 2015 · 10 citations
    5. Effects of the selective TrkA agonist gambogic amide on pigmentation and growth of human hair follicles in vitro PLOS ONE · 2019 · 6 citations
    6. TSPO ligand etifoxine attenuates LPS-induced cognitive dysfunction in mice Brain Research Bulletin · 2020 · 5 citations
    7. Psychotropic Treatment of Psychodermatologic Disorders Actas Dermo-Sifiliográficas · 2010 · 3 citations
    8. 4-O-Methylhonokiol: A lesser-known neolignan from Magnolia species with diverse and promising pharmacological properties Journal of Applied Pharmaceutical Science · 2022 · 2 citations
    9. Early postnatal allopregnanolone levels alteration and adult behavioral disruption in rats: Implication for drug abuse Neurobiology of Stress · 2019 · 2 citations
    10. Neuroactive Steroids and Ethanol Exposure: Relevance to Ethanol Sensitivity and Alcohol Use Disorders Risk Elsevier eBooks · 2019 · 1 citations
    11. The Impact of the 5α-Reductase Inhibitors (5α-RIs) on Male Sexual Function and Psychological Well-Being Current Sexual Health Reports · 2015 · 1 citations
    12. Role of neurosteroids in ischemic postconditioning-induced attenuation of cerebral ischemia-evoked neuronal injury and behavioral deficits in mice Der pharmacia lettre · 2015 · 1 citations
    13. Drug Repurposing Patent Applications July–September 2025 Drug repurposing · 2025
    14. Issues in the Treatment of Epilepsy Epilepsia · 2001 · 4 citations
    15. A Case of Hemi‐Isaac's Syndrome Movement disorders clinical practice · 2021 · 1 citations
    16. The IVIG treatment response in autoimmune polyendocrine syndromes type 2 with anti-GAD65 antibody-associated stiff person syndrome: a case report and literature review Frontiers in Immunology · 2025
    17. The Neurobiology of Sexual Function Archives of General Psychiatry · 2000 · 393 citations
    18. Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients The Journal of Sexual Medicine · 2010 · 223 citations
    19. Hormesis and medicine British Journal of Clinical Pharmacology · 2008 · 127 citations
    20. Central Opioid Inhibition of Neuroendocrine Stress Responses in Pregnancy in the Rat Is Induced by the Neurosteroid Allopregnanolone Journal of Neuroscience · 2009 · 123 citations
    21. Pharmacological evidences for the extracts and secondary metabolites from plants of the genus Hibiscus Food Chemistry · 2009 · 120 citations
    22. Potassium channel openers: pharmacological and clinical aspects Fundamental & Clinical Pharmacology · 1992 · 119 citations
    23. Lignans and Neolignans: Plant secondary metabolites as a reservoir of biologically active substances Pharmacological Research · 2019 · 112 citations
    24. Finasteride induced depression: a prospective study BMC clinical pharmacology · 2006 · 99 citations
    25. The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression Korean Journal of Urology · 2014 · 75 citations
    26. Steroid 5α-Reductase as a Novel Therapeutic Target for Schizophrenia and Other Neuropsychiatric Disorders Current Pharmaceutical Design · 2011 · 72 citations
    27. Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation Expert Opinion on Drug Safety · 2012 · 71 citations
    28. Sexual dysfunction in subjects treated with inhibitors of 5α-reductase for benign prostatic hyperplasia: a comprehensive review and meta-analysis International Journal of Andrology · 2017 · 66 citations
    29. Relationships between cerebrospinal fluid GABAergic neurosteroid levels and symptom severity in men with PTSD Psychoneuroendocrinology · 2018 · 59 citations
    30. COVID-19: Understanding Inter-Individual Variability and Implications for Precision Medicine Mayo Clinic Proceedings · 2020 · 58 citations